Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results

Gatell, Jose ; Ceron, Dominique Salmon ; Lazzarin, Adriano ; Wijngaerden, Eric Van ; Antunes, Francisco ; Leen, Clifford ; Horban, Andrzej ; Wirtz, Victoria ; Odeshoo, Linda ; Dungen, Monique Van den ; Gruber, Claudia ; Ledesma, Emilio

Clinical infectious diseases, 2007-06, Vol.44 (11), p.1484-1492 [Periódico revisado por pares]

Chicago, IL: The University of Chicago Press

Texto completo disponível